Éric Jourdan
Impact in
- Genetics top 1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
Papers in
- Genetics 20
- Myeloproliferative Neoplasms: Diagnosis and Treatment 17
- Chronic Lymphocytic Leukemia Research 2
-
- Acute Myeloid Leukemia Research 4
- Multiple Myeloma Research and Treatments 3
- Co-authors
- Claire Harrison (9 shared papers)Alessandro Maria Vannucchi (9 shared papers)Ruben A. Mesa (7 shared papers)Francesco Passamonti (7 shared papers)Animesh Dev Pardanani (4 shared papers)Nicolaas PM Schaap (4 shared papers)Richard T. Silver (4 shared papers)Elena Mishchenko (5 shared papers)
- Journals
- Blood (11 papers)American Journal of Hematology (4 papers)HemaSphere (2 papers)European Journal Of Haematology (2 papers)British Journal of Haematology (2 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Éric Jourdan
41 papers receiving 1.9k citations
Éric Jourdan's Hit Papers
Peers
Comparison fields: 5 of 58
- Genetics 816
- Hematology 290
- Cell Biology 76
- Pulmonary and Respiratory Medicine 127
- Oncology 81
Countries citing papers authored by Éric Jourdan
This map shows the geographic impact of Éric Jourdan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Jourdan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Jourdan more than expected).
Fields of papers citing papers by Éric Jourdan
This network shows the impact of papers produced by Éric Jourdan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Jourdan. The network helps show where Éric Jourdan may publish in the future.
Co-authors
The 25 scholars most cited alongside Éric Jourdan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis Hit paper breakdown → | 2015 | 411 |
| 2 | 2017 | 274 | |
| 3 | 2003 | 190 | |
| 4 | 2020 | 128 | |
| 5 | 2007 | 123 | |
| 6 | 2011 | 104 | |
| 7 | 2009 | 100 | |
| 8 | 2018 | 69 | |
| 9 | 2021 | 51 | |
| 10 | 2001 | 47 | |
| 11 | 1995 | 37 | |
| 12 | 2006 | 34 | |
| 13 | 2022 | 33 | |
| 14 | 2011 | 30 | |
| 15 | 2013 | 28 | |
| 16 | 2003 | 27 | |
| 17 | 2002 | 26 | |
| 18 | 2021 | 21 | |
| 19 | 2022 | 21 | |
| 20 | 2007 | 19 |
About Éric Jourdan
Éric Jourdan is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Nutrition and Dietetics and Cell Biology, having authored 45 papers that have together received 1.9k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (17 papers), Lymphoma Diagnosis and Treatment (5 papers), Acute Myeloid Leukemia Research (4 papers), Multiple Myeloma Research and Treatments (3 papers), Trace Elements in Health (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Methemoglobinemia and Tumor Lysis Syndrome (1 paper) and Proteoglycans and glycosaminoglycans research (1 paper). The work is most often cited by research in Genetics (816 citations), Hematology (290 citations), Cell Biology (76 citations), Pulmonary and Respiratory Medicine (127 citations) and Oncology (81 citations). Éric Jourdan has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Claire Harrison, Alessandro Maria Vannucchi, Ruben A. Mesa, Francesco Passamonti, Animesh Dev Pardanani, Nicolaas PM Schaap, Richard T. Silver, Elena Mishchenko, Ayalew Tefferi and Moshe Talpaz. Their work appears in journals such as Blood, American Journal of Hematology, HemaSphere, European Journal Of Haematology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.